FindTrial
Sign In

ROLE OF HOMOEOPATHIC MEDICINE IN DIABETES MELLITUS 2

A CLINICAL PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE THE EFFECTIVENESS OF INDIVIDULISED HOMOEOPATHIC MEDICINE IN DIABETES MELLITUS 2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039691
Enrollment
36
Registered
2022-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

Intervention1: NIL: NIL

Sponsors

SUNIL THUMAR
Lead Sponsor
DR JAGDISH THEBAR
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 A diagnosed or first time diagnose case of DM 2 with blood investigation according to diagnostic test and including Symptomatic and Asymptomatic category. 2 In these Cases patients of any age and both sexes are included. 3 All type of socio-economic status patients.

Exclusion criteria

Exclusion criteria: 1 Critical patient who have acute metabolic complication with known case of DM 2. 2 Patients with serious cardiac disorder, asthma or its previous history and other terminal illness.

Design outcomes

Primary

MeasureTime frame
To study the effectiveness of individualized homoeopathic medicine in DM 2.Timepoint: it will be assessed at baseline and at the end of 3 months of duration—

Secondary

MeasureTime frame
To understand the clinical progress of DM 2 according to DM 2 criteria.Timepoint: 1 YEARS—

Countries

India

Contacts

Public ContactDR JAGDISH THEBAR

SWASTHYA KALYAN HOMOEOPATHIC MEDICAL COLLEGE and RESEARCH CENTRE SITAPURA JAIPUR

thebarjagdish@gmail.com9829391362

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026